1,3-dicyclohexylurea has been researched along with Blood Pressure, Low in 1 studies
1,3-dicyclohexylurea: degradation product of 1-(2-chloroethyl)-3- cyclohexyl-1-nitrosourea; structure
| Excerpt | Relevance | Reference |
|---|---|---|
| "05 nM) had excellent oral bioavailability (98%, n = 2) and blood area under the curve in dogs and was effective in vivo to treat hypotension in lipopolysaccharide challenged murine models." | 1.34 | Orally bioavailable potent soluble epoxide hydrolase inhibitors. ( Hammock, BD; Hwang, SH; Liu, JY; Morisseau, C; Tsai, HJ, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, SH | 1 |
| Tsai, HJ | 1 |
| Liu, JY | 1 |
| Morisseau, C | 1 |
| Hammock, BD | 1 |
1 other study available for 1,3-dicyclohexylurea and Blood Pressure, Low
| Article | Year |
|---|---|
Orally bioavailable potent soluble epoxide hydrolase inhibitors.
Topics: Adamantane; Administration, Oral; Animals; Benzoates; Biological Availability; Cats; Cricetinae; Dog | 2007 |